| GC16829-10mg |
|
144110-38-3 |
Arphamenine B (hemisulfate)
|
0 |
C16H24N4O4 • 1/2H2SO4 |
|
|
|
| GC16829-5mg |
|
144110-38-3 |
Arphamenine B (hemisulfate)
|
0 |
C16H24N4O4 • 1/2H2SO4 |
|
|
|
| GC16829-1mg |
|
144110-38-3 |
Arphamenine B (hemisulfate)
|
0 |
C16H24N4O4 • 1/2H2SO4 |
|
|
|
| GC16828-10mM (in 1mL DMSO) |
|
477600-75-2 |
Tofacitinib (CP-690550,Tasocitinib)
|
0 |
C16H20N6O |
|
|
|
| GC16828-50mg |
|
477600-75-2 |
Tofacitinib (CP-690550,Tasocitinib)
|
0 |
C16H20N6O |
|
|
|
| GC16828-10mg |
|
477600-75-2 |
Tofacitinib (CP-690550,Tasocitinib)
|
0 |
C16H20N6O |
|
|
|
| GC16827-10mM (in 1mL DMSO) |
|
1233948-35-0 |
|
0 |
C19H16N2O2S2 |
|
|
|
| GC16827-25mg |
|
1233948-35-0 |
|
0 |
C19H16N2O2S2 |
|
|
|
| GC16827-10mg |
|
1233948-35-0 |
|
0 |
C19H16N2O2S2 |
|
|
|
| GC16827-5mg |
|
1233948-35-0 |
|
0 |
C19H16N2O2S2 |
|
|
|
| GC16826-50mg |
|
85146-53-8 |
|
0 |
C20H33NO |
|
|
|
| GC16826-25mg |
|
85146-53-8 |
|
0 |
C20H33NO |
|
|
|
| GC16826-10mg |
|
85146-53-8 |
|
0 |
C20H33NO |
|
|
|
| GC16826-5mg |
|
85146-53-8 |
|
0 |
C20H33NO |
|
|
|
| GC16825-10mM (in 1mL DMSO) |
|
57-66-9 |
|
0 |
C13H19NO4S |
|
|
|
| GC16825-50mg |
|
57-66-9 |
|
0 |
C13H19NO4S |
|
|
|
| GC16824-10mM (in 1mL DMSO) |
|
306-07-0 |
Pargyline (hydrochloride)
|
0 |
C11H13N • HCl |
|
|
|
| GC16824-5g |
|
306-07-0 |
Pargyline (hydrochloride)
|
0 |
C11H13N • HCl |
|
|
|
| GC16824-1g |
|
306-07-0 |
Pargyline (hydrochloride)
|
0 |
C11H13N • HCl |
|
|
|
| GC16823-50mg |
|
11113-62-5 |
|
0 |
C33H57N3O9 (for B) |
|
|
|
